West Pharmaceutical Services, Inc. WST

NYSE | Industrials | Injectable drug packaging and delivery

General analysis — not personal advice.

Signal
HOLD
Sentiment
6/10
Risk
6/10

The incident increases operational risk (potential remediation costs, regulatory exposure, and customer trust impacts), but the rapid recovery and reiterated guidance support waiting for the Q2 print to confirm any margin/cost effects.

This picture changes. Follow West Pharmaceutical Services, Inc. free — email when the signal or risk changes + a Sunday weekly brief.

Follow West Pharmaceutical Services, Inc. free

Email when the signal or risk changes · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Latest news check: 6 Jun 2026
Exchange
NYSE
Type
Industrials
Sector
Injectable drug packaging and delivery

Price & valuation

Last close
USD 351
2026-08-11
1 week
+0.1 %
3 months
+16.2 %
12 months
+46.5 %
From 52w high
-3.9 %
From 52w low
+52.1 %

Market sentiment

Sentiment is neutrally stable: attention has shifted from product/growth narratives to cybersecurity and recovery, but full operational restoration and unchanged guidance have contained negativity.

Why HOLD?

The incident increases operational risk (potential remediation costs, regulatory exposure, and customer trust impacts), but the rapid recovery and reiterated guidance support waiting for the Q2 print to confirm any margin/cost effects.
  • Hold/wait: maintain the position and reassess after Q2 results and any disclosures on incident costs, insurance recoveries, and customer impact.
We're already tracking West Pharmaceutical Services, Inc. — here are the latest events we've registered

Recent News

  • West posted strong Q1 2026 results and raised full-year guidance on robust demand (including GLP-1-related components). It then disclosed a material cyberattack (detected May 4) involving data exfiltration and system encryption, but the latest 8-K/A states core systems, manufacturing, and global shipping are fully restored and management does not expect a material impact to Q2 or full-year 2026 guidance.

Catalysts

Follow-on disclosures on cyber incident costs/liability

What Firelda Watch includes for West Pharmaceutical Services, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — AI roundup of the week's news
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of West Pharmaceutical Services, Inc. will be delivered in the same format.

Own West Pharmaceutical Services, Inc.? Create a free account and follow up to 3 companies — change history, weekly brief, and email when the picture changes. Upgrade to Watch for more slots and same-day alerts.

Follow 3 companies free

Email when the signal or risk changes · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

West Pharmaceutical Services, Inc. WST
West Pharmaceutical Services, Inc. — this picture changes. Follow free
Follow West Pharmaceutical Services, Inc. free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.